Clinical Trial Update: GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant [NA]

View source ↗

Summary

Clinical trial update on GVHD prophylaxis with post-transplant cyclophosphamide in patients with renal insufficiency receiving matched related/unrelated donor a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndrome
• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia, Myelodysplastic Syndrome | NA | Status: TERMINATED | Results posted: 2018-11-08